JNJ

Johnson & Johnson

Halal Rating :
Comfortable
Last Price $147.03 Last updated:
Market Cap $353.99b
7D Change 1.77%
1 Year Change -9.5%
Company Overview Use of Interest Company Impact Justification for our Halal Rating Recent News

Company Overview

Industries
  • Manufacturing
  • Pharmaceutical Products
  • Pharmaceutical Preparations
Exchange NYSE
Next Earnings Date Oct. 15, 2024

Johnson & Johnson is a global healthcare company that focuses on pharmaceutical products, medical devices, and consumer packaged goods. Following the separation of its consumer health business (now Kenvue) in 2023, J&J has concentrated on developing innovative medicines and medical devices. The company's pharmaceutical segment develops treatments for immunology, infectious diseases, neuroscience, oncology, and cardiovascular disease. Its MedTech segment produces a range of products used in orthopedics, surgery, vision care, and interventional solutions.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Sept. 29, 2024 $22.47b $17.63b - $193.0m 0.00% 1.09%
June 30, 2024 $22.45b $16.44b - $270.0m 0.00% 1.64%
March 31, 2024 $21.38b $15.63b - $155.0m 0.00% 0.99%

Company Impact

Help us evaluate Johnson & Johnson's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Contribute

Recent News & Updates